Señales en vivo de APGE | Maximiza tus Ganancias con Getagraph.com

COMPRAR 136828 min ago

@ $35.28

Emitido: 14 feb 2024 @ 15:02

Retorno: 42.60%

Señal anterior: feb 13 - 12:37

Señal anterior: Vender

Retorno: 0.28 %

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Stats
Volumen de hoy	379 725
Volumen promedio	711 880
Capitalización de mercado	2.94B
EPS	$0 ( 2024-03-11 )
Próxima fecha de ganancias	( $-0.600 ) 2024-06-04
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0850 (0.17%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-29	Fairmount Funds Management Llc	Buy	51 166	Common Stock
2024-01-29	Fairmount Funds Management Llc	Sell	892 529	Common Stock
2023-12-18	Henderson Michael Thomas	Buy	398 512	Stock Option (Right to Buy)
2023-07-13	Fairmount Funds Management Llc	Buy	1 992 734	Common Stock
2023-07-13	Fairmount Funds Management Llc	Buy	892 529	Common Stock

INSIDER POWER
47.02
Last 9 transactions
Buy: 3 438 612 \| Sell: 892 529

Volumen Correlación

Largo: -0.38 (neutral)

Corto: -0.67 (moderate negative)

Signal:(42.984) Neutral

Apogee Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Apogee Therapeutics, Inc. Correlación - Moneda/Commodity

-0.78
( moderate negative )

-0.67
( moderate negative )

-0.78
( moderate negative )

-0.71
( moderate negative )

-0.73
( moderate negative )

0.72
( moderate )

Apogee Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-1.660

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-1.660

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-0.790

Financial Reports:

No articles found.

Apogee Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Apogee Therapeutics, Inc.

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.